(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with am 630 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allarà, M; Benetti, V; Cascio, MG; Di Marzo, V; Ferrarini, PL; Ghelardini, C; Manera, C; Martinelli, A; Saccomanni, G; Tuccinardi, T; Vivoli, E | 1 |
| Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A | 1 |
| Allarà, M; Di Marzo, V; Escobar, R; Faúndez, M; Iturriaga-Vásquez, P; Mella-Raipán, J; Palmieri, V; Pessoa-Mahana, CD; Pessoa-Mahana, H; Romero-Parra, J; Torres, MJ | 1 |
| Cooper, AG; Glass, M; Hook, S; MacDonald, C; Tyndall, JDA; Vernall, AJ | 1 |
| Abate, M; Arena, C; Bertini, S; Bifulco, M; Chicca, A; Ciaglia, E; Digiacomo, M; Gado, F; Gertsch, J; Lapillo, M; Macchia, M; Manera, C; Poli, G; Tuccinardi, T | 1 |
| Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
1 review(s) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and am 630
| Article | Year |
|---|---|
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
5 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and am 630
| Article | Year |
|---|---|
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists.
Topics: Animals; Cell Line; Humans; Mice; Naphthyridines; Pain Measurement; Quinolines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism | 2011 |
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Drug Design; Humans; Molecular Docking Simulation; Protein Binding; Protein Conformation; Receptor, Cannabinoid, CB2; Thiophenes | 2016 |
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.
Topics: Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Ligands; Models, Molecular; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2018 |
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system.
Topics: Dose-Response Relationship, Drug; Endocannabinoids; Humans; Molecular Docking Simulation; Molecular Structure; Pyridines; Receptors, Cannabinoid; Structure-Activity Relationship; Tumor Cells, Cultured; U937 Cells | 2018 |